Last updated on June 2019

DE-117 Spectrum 5 Study

Brief description of study

Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost/non-responder subjects diagnosed with POAG or OHT

Clinical Study Identifier: NCT03697811

Find a site near you

Start Over

Arizona Eye Center

Chandler, AZ United States
  Connect »